Antipsychotic potential of the type 1 cannabinoid receptor positive allosteric modulator GAT211: preclinical in vitro and in vivo studies.

Dan L McElroyAndrew J RoebuckGavin A ScottQuentin GrebaSumanta GaraiEileen M Denovan-WrightGanesh A ThakurRobert B LaprairieJohn G Howland

Published in: Psychopharmacology (2021)

Taken together, these findings support continued preclinical research regarding the usefulness of CB1R positive allosteric modulators as antipsychotics.

Keyphrases

small molecule
cell therapy
stem cells
bone marrow